Avenue Therapeutics Inc. (NASDAQ:ATXI) went up by 105.90% from its latest closing price compared to the recent 1-year high of $1.85. The company’s stock price has collected 64.79% of gains in the last five trading sessions.
Is It Worth Investing in Avenue Therapeutics Inc. (NASDAQ :ATXI) Right Now?
Plus, the 36-month beta value for ATXI is at 0.92.
ATXI currently public float of 10.28M and currently shorts hold a 1.47% ratio of that float. Today, the average trading volume of ATXI was 1.43M shares.
ATXI’s Market Performance
ATXI stocks went up by 64.79% for the week, with a monthly jump of 70.41% and a quarterly performance of 75.09%, while its annual performance rate touched -71.61%. The volatility ratio for the week stands at 44.27% while the volatility levels for the past 30 days are set at 30.35% for Avenue Therapeutics Inc. The simple moving average for the period of the last 20 days is 78.59% for ATXI stocks with a simple moving average of -9.95% for the last 200 days.
ATXI Trading at 65.81% from the 50-Day Moving Average
After a stumble in the market that brought ATXI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.22% of loss for the given period.
Volatility was left at 30.35%, however, over the last 30 days, the volatility rate increased by 44.27%, as shares surge +71.87% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +62.30% upper at present.
During the last 5 trading sessions, ATXI rose by +64.79%, which changed the moving average for the period of 200-days by -66.41% in comparison to the 20-day moving average, which settled at $0.2556. In addition, Avenue Therapeutics Inc. saw -51.54% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ATXI
Equity return is now at value -415.90, with -275.90 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 7.78.